Navigation Links
Plato BioPharma Presenting Preclinical capabilities at PKPD Summit Boston
Date:3/19/2013

WESTMINSTER, Colo., March 19, 2013 /PRNewswire/ -- Plato BioPharma, Inc. (PBI) will be presenting their integrated pharmacology capabilities at the "PKPD Summit Boston" in Boston, Massachusetts on March 20, 2013.  The presentation will overview PBI's integrated pharmacology approach.  The presentation will be delivered by Drs. Glenn J. Smits , PhD and Craig F. Plato , PhD, President of Plato BioPharma, Inc.

"Clients trust PBI to deliver complex preclinical proof of concept studies due to our extensive industry experience in disease modeling and discovery pharmacology.  We're participating in the PKPD Summit to detail our broader capabilities and expertise in drug discovery.  We appreciate the challenges of translating preclinical work, and believe PBI is well-positioned to address these challenges and provide disease-relevant PK and PD approaches.  We strive to bring a more creative and partnering approach to the preclinical paradigm to deliver the highest quality science while decreasing the time for enabling decisions thus minimizing cost," said Dr. Plato.

Founded in 2009, Plato BioPharma, Inc. is a leading preclinical contract research organization (CRO).  The company offers expert drug discovery and development capabilities in cardiovascular, renal, pulmonary, and hepatic disease therapeutic areas.  PBI provides an integrated research platform from the in-life phase through clinical chemistry, biomarker and histological analyses.  The company specializes in custom study design and execution of engagements ranging from pharmacokinetics through disease model development and proof-of-concept evaluation.  PBI is headquartered in Westminster, Colorado.

Contact: Bob Leahy
Phone: 303-506-6960
Email: bleahy@platobiopharma.com
Website: www.platobiopharma.com


'/>"/>
SOURCE Plato BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. La célebre chef Leticia Moreinos Schwartz se asocia con Merck en el marco del programa Cuida tu Diabetes, Cuida tu Corazón para preparar deliciosos platos para diabéticos destinados a los hispanos que padecen diabetes tipo 2
2. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
3. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
4. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
5. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
6. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
7. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
8. S1 Biopharma Expands Focus to Include Male Sexual Health
9. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
10. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
11. Cell Therapeutics Aequus BioPharma Validates its Proprietary GlycoPolymer Technology for the Extension of the Half-life of Therapeutic Protein Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... 2, 2017 Halo Labs announces the European launch of ... the HORIZON at MIBio 2017 in Cambridge, U.K ... particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity while ... technique Backgrounded Membrane Imaging. ... HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
Breaking Medicine News(10 mins):